A practical approach to the classification of MDS

In this video, Rashmi Kanagal-Shamanna, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, gives an overview of current approaches to the classification of myelodysplastic syndromes (MDS), and how these may be improved. Dr Kanagal-Shamanna first highlights the importance of identifying genomic aberrations in patients with MDS, and then comments on the importance of using novel technologies and combining multiple techniques to better diagnose disease and enable precision medicine.This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.